Tsingke Biotech Showcases AI Biomanufacturing Platforms at Festival of Biologics 2025
Beijing-based Tsingke Biotech Co., Ltd. showcased its AI-powered biomanufacturing platforms at the 2025 Festival of Biologics in Basel, announced in a press release. The event gathered over 2,000 biotech experts from 50 countries to explore innovations in biologics research and production.
Tsingke presented integrated solutions covering gene and RNA design, antibody discovery, and GMP-grade biologics manufacturing. The company highlighted how AI and next-generation sequencing are redefining antibody and protein engineering, enabling early process validation during discovery.
Describing itself as a full-stack "Gene Factory," Tsingke demonstrated capabilities in high-throughput gene synthesis, chemically modified oligonucleotides for ADC, PROTAC, and AOC research, and optimized nucleic acid purification and LNP encapsulation. These tools aim to link laboratory-scale research with industrial-scale manufacturing.
Tsingke’s ISO 13485–certified facilities and automated production systems support its goal of accelerating drug discovery and genetic engineering through digital design and precision synthesis.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Systech Launches TraceIQ for Pharmaceutical Supply Chains
Taiwan Innotech Expo 2026 to Feature 1,039 Technologies
Global Sources Hong Kong Shows to Feature 1,200 AI Booths
Daily AI Brief: the AI news that matters, in your inbox.